Skip to main content
Porto

PMMNG logo

  • Home
  • News
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
    • Upcoming Events
    • Archived Myeloma Events
  • Our Members
  • Miles for Myeloma
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Archived Events
  • March 2021 PMMNG Meeting - Patient - Caregiver Split
  • MMRF: Expert Session
  • CancerCare: Current Perspectives on Cancer Survivorship
  • Myeloma Crowd: American Society of Hematology Meeting Review
  • MMRF: Patient Summit – Virtual Web Conference
  • Myeloma Crowd: Multiple Myeloma Care in 2021
  • IMF: Best of ASH 2020
  • MMRF: Expert Session on Smoldering Myeloma
  • MMRF: Multiple Myeloma Highlights From the 2020 American Society of Hematology (ASH) Meeting & Exposition
  • Myeloma Crowd: The IMPACT of COVID-19 on MGUS, Smoldering Myeloma, African Americans and Myeloma Patient Family Members

Myeloma Crowd: Multiple Myeloma Care in 2021

Myeloma Crowd logoWhat: Webcast audio (1:23:20)
When: Friday January 22, 2021 4:00 PM ET
Where: Web
Access audio and transcript

Tags
event
webcast
archived
clinical trials
ash
combination therapies
newly diagnosed myeloma
expected fda approvals
car-t
bispecific and trispecific antibodies
antibody drug conjugates
targeted inhibitors
mgus
smoldering myeloma
Dr. Robert Orlowski